Novamont among the speakers of the Bioeconomy Investment Summit in Helsinki

  thursday 14th december 2017

Share

Novamont among the speakers of the Bioeconomy Investment Summit in Helsinki

From the 14th to the 15th of  December Helsinki hosted the Bioeconomy Investment Summit 2017, a follow-up of the Bioeconomy Investment Summit organized by the European Union in 2015 and of the Lodz Bioeconomy Congress and the Bratislava Bioeconomy Conference in 2016.
 
During the summit about thirty speakers discussed on how to turn bioeconomy from "niche sector to norm" and how it will be possible to attract public investments to build a sustainable future. The discussion touched the regulatory policies, the bio-based product chains, the financing and market opportunities and how to overcome all the barriers and obstacles to address the investments.
 
The first day of the summit Giulia Gregori, head of Novamont’s Strategic planning and institutional communication, has taken part in the opening session "A new paradigm for a new era" and in particular the "Panel Discussion on the bioeconomy paradigm: opportunities and challenges", with Frank Goebel, member of the board of directors, B.R.A.I.N. Aktiengesellschaft, Pentti Hyttinen of Metsahallitus and Teresa Ribera, Director of the Institute for Sustainable Development and International Relations.
 
During the two rounds of discussion, moderated by Christian Patermann (BioEconomy Council of the Federal German Government.), the speakers confronted each other on the opportunities of the bioeconomy and  on how to face the obstacles and the unexpected problems to attract investments.
 
Giulia Gregori had the chance to outline Novamont’s holist approach in connecting all the stakeholders involved in the biobased chemical value chain, approach that can lead to a reindustrialization of Europe has appended in the plant in Bottrighe where bio 1,4-BDO is produced. Gregori also highlighted the important contribution that tools like BBI-JU have in the development of the bioeconomy and the challenge that the sector is facing: scaling up from laboratory technologies to flagship plants, which can happen only building synergies among the private and public sector, calling on the European Union to set the right scene with smart policies capable of developing the sector.